Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

676580.pdf (461.62 KB)

Document type

Article

Version

Accepted version

Publication date

2017-06-01

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/167357

The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1111/trf.14071

Abstract

BACKGROUNDThe parasitic Chagas disease is caused by the protozoan Trypanosoma cruzi, which is mainly transmitted by insect vectors. Other infection routes, both in endemic and in nonendemic areas, include organ and marrow transplantation, congenital transmission, and blood transfusion. Asymptomatic chronic chagasic individuals may have a low and transient parasitemia in peripheral blood and, consequently, they can unknowingly transmit the disease via blood transfusion. Riboflavin and ultraviolet (UV) light pathogen reduction is a method to reduce pathogen transfusion transmission risk based on damage to the pathogen nucleic acids.STUDY DESIGN AND METHODSIn this study, we tested the effectiveness of this technology for the elimination of T. cruzi parasites in artificially contaminated whole blood units (WBUs) and thus for decreasing the risk of T. cruzi transfusion transmission. The contaminated WBUs were leukoreduced by filtration and treated with riboflavin and UV light. The level of pathogen reduction was quantified by a real-time polymerase chain reaction (qPCR) and a real-time reverse transcription-polymerase chain reaction (RT-qPCR) as a viability assay.RESULTSThe RNA (cDNA) quantification of the parasites showed a more than 99% reduction of viable T. cruzi parasites after leukoreduction and a complete reduction (100%) after the riboflavin and UV light treatment.CONCLUSIONRiboflavin and UV light treatment and leukoreduction used in conjunction appears to eliminate significant amounts of viable T. cruzi in whole blood. Both strategies could complement other blood bank measures already implemented to prevent the transmission of T. cruzi via blood transfusion.

Subject

Malaltia de Chagas, Farmacologia, Parasitologia, Virulència (Microbiologia), Malalties parasitàries, Transfusió de sang

Subject (English)

Chagas' disease, Pharmacology, Parasitology, Virulence (Microbiology), Parasitic diseases, Blood transfusion

Citation

Collections

Articles publicats en revistes (Biologia, Sanitat i Medi Ambient)

Citation

JIMENEZ-MARCO, Teresa, et al. The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood. Transfusion. 2017. Vol. 57, num. 6, pags. 1440-1447. ISSN 0041-1132. [consulted: 13 of August of 2026]. Available at: https://hdl.handle.net/2445/167357

Export metadata

JSON - METS

Share record